On the public citation graph

Discontinuation of Direct Oral Anticoagulants in Response to Attorney Advertisements: Data From the FDA Adverse Event Reporting System

https://doi.org/10.1177/1060028019849664
0 signed · 9 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s40264-015-0340-6openalex-snapshot
Association of Attorney Advertising and FDA Action with Prescription Claims: A Time Series Segmented Regression Analysis
inferredcites →https://doi.org/10.1016/j.hrcr.2016.02.001openalex-snapshot
A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising
inferredcites →https://doi.org/10.1016/j.jacc.2012.09.057openalex-snapshot
Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
inferredcites →https://doi.org/10.1016/j.urology.2014.03.051openalex-snapshot
Patient Perception of Transvaginal Mesh and the Media
inferredcites →https://doi.org/10.1177/0098858815591508openalex-snapshot
Medical Advice from Lawyers: A Content Analysis of Advertising for Drug Injury Lawsuits.

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4713136openalex-extracted
inferred← citeshttps://doi.org/10.1002/phar.2457openalex-snapshot
Impact of Hospitalization and Medication Switching on Post‐discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation
inferred← citeshttps://doi.org/10.1016/j.sapharm.2021.08.011openalex-snapshot
Effects of conflicting prescription drug information from direct-to-consumer advertising and drug injury advertising on patients’ beliefs and medication adherence
inferred← citeshttps://doi.org/10.1287/mnsc.2023.04294openalex-snapshot
Bad-Drug Ads or Killer Ads: The Effects of Drug Injury Advertising on Public Health
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.